Medicare prescription drug cost, prescriptions and prescribers, 2024
Medicare cost, 2024
$14.9M
+35.1% from 2023
Prescriptions
980
$15,208.69 per claim
Patients
159
188 prescribers
Total spending, 2024
$14.9M
$93,739.12 per patient
Medicare prescription drug plans paid $14.9M for Gavreto in 2024, for 980 prescriptions and refills to 159 patients (up 35.1% from 2023). The average cost per claim was $15,208.69.
California had the highest Medicare cost for Gavreto in 2024: $2.7M for 158 claims, followed by Texas ($1.9M).
Mimi I Hu, endocrinology in Houston, TX, had the highest Medicare cost for Gavreto in 2024: 29 claims costing $507K.
All plans and makers
Where the prescribers practice, 2024
By Medicare drug cost
| Prescriber | Type | Claims | Patients | Cost |
|---|---|---|---|---|
| Mimi I Hu Houston, TX | Endocrinology | 29 | Under 11 | $507K |
| Krzysztof J Misiukiewicz New York, NY | Medical Oncology | 24 | Under 11 | $387K |
| Ashish Saxena |
| Year | Prescribers | Claims | Patients | Cost |
|---|---|---|---|---|
| 2022 | 116 | 519 | 104 | $8.4M |
| 2023 | 158 | 664 | 129 | $11.0M |
| 2024 | 188 | 980 | 159 | $14.9M |
Amount reimbursed by state Medicaid programs, all states
More drugs: top Medicare drugs by cost and the Prescriptions tab.
Official US government data on Medicare prescription drug plans (Part D) and Medicaid drug use. Cost and spending are before the rebates drug makers pay. Prescribers with fewer than 11 claims of the drug are not published.
| Medical Oncology |
| 21 |
| Under 11 |
| $371K |
| Lauren A Byers Houston, TX | Medical Oncology | 13 | Under 11 | $290K |
| Mabel M Ryder Rochester, MN | Endocrinology | 21 | Under 11 | $278K |
| Sam Mazj Chico, CA | Hematology-Oncology | 13 | Under 11 | $267K |
| Hussein Assi Boston, MA | Medical Oncology | 13 | Under 11 | $256K |
| Ticiana B Leal Atlanta, GA | Medical Oncology | 13 | Under 11 | $256K |
| Ammar Sukari Detroit, MI | Medical Oncology | 12 | Under 11 | $254K |
| Mary Carroll Orange, CA | Nurse Practitioner | 18 | Under 11 | $249K |
| Steven B Newman Naples, FL | Internal Medicine | 11 | Under 11 | $246K |
| 1417916537 | Internal Medicine | 11 | Under 11 | $236K |
| Raja S Mehdi Las Vegas, NV | Medical Oncology | 12 | Under 11 | $235K |
| Thomas R Buroker Ankeny, IA | Medical Oncology | 11 | Under 11 | $217K |
| Adi Gidron Highland Park, IL | Hematology-Oncology | 13 | Under 11 | $208K |
| Samuel W Chung Jr. South Pasadena, CA | Medical Oncology | 12 | Under 11 | $202K |
| Todd Clover Bend, OR | Medical Oncology | 16 | Under 11 | $200K |
| Stephen Liu Los Angeles, CA | Hematology-Oncology | 16 | Under 11 | $192K |
| Gregory P Kalemkerian Ann Arbor, MI | Medical Oncology | 11 | Under 11 | $186K |
| James E Butrynski Eugene, OR | Medical Oncology | 13 | Under 11 | $149K |
| Brian C Sutton San Diego, CA | Physician Assistant | 11 | Under 11 | $146K |
| Jun Zhang Iowa City, IA | Medical Oncology | 11 | Under 11 | $142K |
| Jeremy P Cetnar Portland, OR | Medical Oncology | 12 | Under 11 | $136K |
| Daniel Bowles Aurora, CO | Hematology-Oncology | 24 | Under 11 | $127K |
| Megan T Cannon Richmond, VA | Nurse Practitioner | 11 | Under 11 | $125K |
Spending by manufacturer as listed in the spending data